Search

New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.

… Sunday, June 5, 2022 Update: On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low  breast cancer  that has spread to other parts of the body and is unable to be surgically removed. The drug,  https://www.mskcc.org/cancer-care/patient-education/fam-trastuzumab-deruxtecan

Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human disease with a focus on cancer.

… Monday, May 17, 2021 Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Tuesday, April 30, 2024 Victoria Blinder Awarded Funding from the Patient-Centered Outcomes Research Institute Victoria Blinder, MD, FASCO Victoria Blinder, MD, FASCO , medical oncologist, was  awarded funding from the Patient-Centered Outcomes Research Institute (PCORI) on behalf of the Alliance NCTN

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.

… Friday, January 1, 2021 Dana Pe’er is Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI). She came to Memorial Sloan Kettering Cancer Center in 2016, with the goal of bringing her mathematical and computational expertise to bear on the problem of cancer. An

Get to know Ana Silveira, a computational biology postdoctoral fellow in the Sloan Kettering Institute.

… Thursday, March 26, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Ana Silveira is a postdoctoral fellow in the Chodera lab  in the Sloan Kettering Institute. When you look back

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.

… Tuesday, July 19, 2016 Summary Soft tissue sarcoma describes a group of rare cancers that grow in the body’s supportive and connective tissues. MSK investigators are improving the diagnosis and treatment of sarcoma. Highlights Research into the genetic causes of sarcoma is leading to a better understanding

Memorial Sloan Kettering's Junior Faculty Council presented its 2008 Award for Excellence in Mentoring to Alan N. Houghton, Vice Chair for Academic Affairs in the Department of Medicine and incumbent of the Virginia and Daniel K. Ludwig Clinical Chair.

… Wednesday, October 1, 2008 Summary Memorial Sloan Kettering’s Junior Faculty Council presented its 2008 Award for Excellence in Mentoring to Alan N. Houghton, Vice Chair for Academic Affairs in the Department of Medicine and incumbent of the Virginia and Daniel K. Ludwig Clinical Chair. On June 17, Memorial

OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.

… Thursday, November 4, 2021 The ability of doctors to match the correct treatment to a patient’s cancer just took a major step forward, when a genetic variant database developed at Memorial Sloan Kettering Cancer Center became the first to achieve partial recognition from the US Food and Drug Administration

Memorial Sloan Kettering Cancer Center physician-scientist Charles L. Sawyers has been named a recipient of the 2009 Lasker~DeBakey Award for Clinical Medical Research.

… Monday, September 14, 2009 Memorial Sloan Kettering Cancer Center (MSKCC) physician-scientist Charles L. Sawyers has been named a recipient of the 2009 Lasker~DeBakey Award for Clinical Medical Research. Dr. Sawyers is Chair of the Human Oncology and Pathogenesis Program (HOPP) within Memorial Hospital

Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment.

… Thursday, June 6, 2024 If you’re diagnosed with cancer, your first instinct may be to get it treated right away because there’s not a moment to waste. But what if your doctor says you don’t need treatment? For some types of cancer, especially those that are early-stage and are unlikely to spread and